MODERIL Drug Patent Profile
✉ Email this page to a colleague
When do Moderil patents expire, and when can generic versions of Moderil launch?
Moderil is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in MODERIL is rescinnamine. There is one drug master file entry for this compound. Additional details are available on the rescinnamine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MODERIL?
- What are the global sales for MODERIL?
- What is Average Wholesale Price for MODERIL?
Summary for MODERIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 32 |
| Patent Applications: | 834 |
| DailyMed Link: | MODERIL at DailyMed |
US Patents and Regulatory Information for MODERIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | MODERIL | rescinnamine | TABLET;ORAL | 010686-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pfizer | MODERIL | rescinnamine | TABLET;ORAL | 010686-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
